Overview
- The directive does not legalize recreational marijuana or change federal criminal penalties, with cannabis remaining illegal under federal law.
- The order initiates a formal DOJ/DEA process rather than an immediate change in classification, with timing uncertain and public comment still required.
- CMS announced a pilot to allow certain Medicare beneficiaries access to lawful CBD products starting as early as April 2026.
- Rescheduling is intended to expand medical research and could relieve cannabis businesses of Section 280E tax restrictions, potentially improving access to banking.
- Reaction split along party lines, with organized Republican opposition via letters to the White House and Democratic leaders welcoming the shift.